234
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Clinical Value of Hospital-Community-Family Integrated Nursing Model in the Treatment of Patients with Hyperlipidemia Pancreatitis

, , , , &
Pages 3219-3227 | Received 19 May 2023, Accepted 18 Jul 2023, Published online: 31 Jul 2023

References

  • Liu Y, Sun Y, Xue BH, et al. Negative regulation of SIRT1 by IRF9 involved in hyperlipidemia acute pancreatitis associated with kidney injury. Dig Dis Sci. 2021;66(4):1063–1071. doi:10.1007/s10620-020-06331-1
  • Wu Z, Wang X, Jiang X. Study on the mechanism of probucol nanosuspension on hyperlipidemic pancreatitis and regulation of blood lipid function. J Nanosci Nanotechnol. 2021;21(2):1286–1292. doi:10.1166/jnn.2021.18663
  • Renated L, Iversen T, Mogensen PR, et al. Effect of fish oil supplementation on hyperlipidemia during childhood acute lymphoblastic leukemia treatment – a pilot study. Nutr Cancer. 2021;73(9):1816–1820. doi:10.1080/01635581.2020.1803934
  • Liu Y, Sun Y, Xue BH, et al. Negative regulation of SIRT1 by IRF9 involved in hyperlipidemia acute pancreatitis associated with kidney injury. Dig Dis Sci. 2020;66(4):1063–1071.
  • Li X, Li L, Liu L, et al. Risk factors of multidrug resistant pathogens induced infection in severe acute pancreatitis. Shock. 2020;53(3):293–298. doi:10.1097/SHK.0000000000001371
  • Li M, Xing XK, Zhi-Hua L, et al. Comparison of scoring systems in predicting severity and prognosis of hypertriglyceridemia-induced acute pancreatitis. Dig Dis Sci. 2020;65(4):1206–1211. doi:10.1007/s10620-019-05827-9
  • Shan Y, Kong W, Zhu A, Zhang J, Ying R, Zhu W. Increased levels of miR-372 correlate with disease progression in patients with hyperlipidemic acute pancreatitis. Exp Ther Med. 2020;19(6):3845–3850. doi:10.3892/etm.2020.8609
  • Yan Z, Zang B, Gong X, et al. MiR-214-3p exacerbates kidney damages and inflammation induced by hyperlipidemic pancreatitis complicated with acute renal injury. Life Sci. 2020;241:117118.
  • Sardana O, Kumari P, Singh R, Chopra H, Emran TB. Health-related quality of life among acute pancreatitis patients correlates with metabolic variables and associated factors. Ann Med Surg. 2022;82:104504. doi:10.1016/j.amsu.2022.104504
  • Tenner S, Baillie J, DeWitt J, Vege SS. American College of Gastroenterology guideline: management of acute pancreatitis. Off J Am Coll Gastroenterol. 2013;108(9):1400–1415. doi:10.1038/ajg.2013.218
  • Ippisch HM, Alfaro-Cruz L, Fei L, Zou Y, Thompson T, Abu-El-Haija M. Hypertriglyceridemia induced pancreatitis inpatient management at a single pediatric institution. Pancreas. 2020;49(3):429–434. doi:10.1097/MPA.0000000000001505
  • Zhang H, Liu F. Predictive nursing versus routine nursing on health status, cancer-related fatigue and psychological state of patients with pancreatic cancer undergoing chemotherapy. J Mod Nurs Pract Res. 2023;3(1):3. doi:10.53964/jmnpr.2023003
  • Zheng Q, Cao L, Ma H, et al. Evidence-based care can improve treatment compliance and quality of life of patients with acute pancreatitis. J Healthc Eng. 2022;2022:1–8. doi:10.1155/2022/7621658
  • Yang W, Ren S, Liang J. Application and effect of high-quality nursing combined with enteral nutrition support in patients with acute pancreatitis. J Mod Nurs Pract Res. 2021;1(1):1. doi:10.53964/jmnpr.2021001
  • Dongying T, Meifeng W, Ling W. Application of nursing collaboration model in nursing of a patient with severe hyperlipidemia pancreatitis. Chin J Nurs. 2018;53(7):3.
  • Wang S, Wu M. Effects of multidisciplinary specialized nursing care on the short and long-term postoperative quality of life in patients with pancreatic cancer: a randomized controlled trial. J Mod Nurs Pract Res. 2023;3(1):2. doi:10.53964/jmnpr.2023002
  • Zhang L, Zhang L, Wang J, Ding F, Zhang S. Community health service center-based cardiac rehabilitation in patients with coronary heart disease: a prospective study. BMC Health Serv Res. 2017;17(1):1–8. doi:10.1186/s12913-017-2036-3
  • Li J, Chen J, Tang W. The consensus of integrative diagnosis and treatment of acute pancreatitis‐2017. J Evid Based Med. 2019;12(1):76–88. doi:10.1111/jebm.12342
  • Gabriel EH, Hoch MC, Cramer RJ. Health belief model scale and theory of planned behavior scale to assess attitudes and perceptions of injury prevention program participation: an exploratory factor analysis. J Sci Med Sport. 2019;22(5):544–549. doi:10.1016/j.jsams.2018.11.004
  • Yue T, Li Q, Wang R, et al. Comparison of Hospital Anxiety and Depression Scale (Hads) and Zung self-rating anxiety/depression scale (SAS/SDS) in evaluating anxiety and depression in patients with psoriatic arthritis. Dermatology. 2020;236(2):170–178. doi:10.1159/000498848
  • Selim A, Rogers W, Qian S, Rothendler JA, Kent EE, Kazis LE. A new algorithm to build bridges between two patient-reported health outcome instruments: the MOS SF-36® and the VR-12 Health Survey. Qual Life Res. 2018;27(8):2195–2206. doi:10.1007/s11136-018-1850-3
  • Sun Y, Liu Y, Xue B, Wang X, Yu W. Upregulated IRF9 promotes cell apoptosis of hyperlipidemia acute pancreatitis with heart injury by regulating SIRT1. Biocell. 2021;45(1):129. doi:10.32604/biocell.2021.013275
  • Shirolkar A, Yadav A, Mandal TK, Dabur R. Intervention of Ayurvedic drug Tinospora cordifolia attenuates the metabolic alterations in hypertriglyceridemia: a pilot clinical trial. J Diabetes Metab Disord. 2020;19(2):1367–1379. doi:10.1007/s40200-020-00657-3
  • Huang JH, He D, Chen L, et al. GC-MS based metabolomics strategy to distinguish three types of acute pancreatitis. Pancreatology. 2019;19(5):630–637. doi:10.1016/j.pan.2019.05.456
  • Shih HJ, Tsai PS, Wen YC, Kao MC, Fan YC, Huang CJ. Hyperlipidemia patients with long-term statin treatment are associated with a reduced risk of progression of benign prostatic enlargement. Aging Male. 2018;23(5):354–361. doi:10.1080/13685538.2018.1487392
  • Parhofer KG, Laufs U. The diagnosis and treatment of hypertriglyceridemia. Dtsch Arztebl Int. 2019;116(49):825. doi:10.3238/arztebl.2019.0825
  • Fletcher GS. Clinical Epidemiology: The Essentials. Lippincott Williams & Wilkins; 2019.
  • Dong X, Tsang CC, Zhao S, et al. Effects of the Medicare Part D comprehensive medication review on medication adherence among patients with Alzheimer’s disease. Curr Med Res Opin. 2021;37(9):1581–1588. doi:10.1080/03007995.2021.1935224
  • Cong T. Application Research of Internet + “Three-Element Linkage” Management Model of Chronic Hypertension in Hypertension; 2019. Nanjing University of Traditional Chinese Medicine.
  • Pang J, Sullivan DR, Brett T, Kostner KM, Hare DL, Watts GF. Familial hypercholesterolaemia in 2020: a leading tier 1 genomic application. Heart Lung Circ. 2020;29(4):619–633. doi:10.1016/j.hlc.2019.12.002
  • Zhihong Y, Mengjuan L, Yanyan C. Effect of hospital-community-family ternary nursing model combined with continuous nursing on the treatment of patients with coronary heart disease with isosorbide mononitrate. Clin Res. 2021;29(09):165–167.
  • Wei W, Xin Z, Yue L, et al. Application of hospital-community-family ternary nursing model in home care of patients with pressure injury. Chin J Mod Nurs. 2022;28(04):442–446.
  • Chen J, Xiao H, Chen Y, Sun H, Chen S, Zheng J. Effect of reminiscence therapy based on positive psychology theory (RTBPPT) on the positive feelings of the spousal caregivers of elderly patients with advanced cancer in China. Eur J Cancer Care. 2020;29(6):e13324. doi:10.1111/ecc.13324
  • Honghong H, Biyu W, Lanlan C. Development and application analysis of hospital-community-family ternary nursing platform. China Health Stand Manage. 2021;12(16):134–136.
  • Qinghua H, Aiying H. Analysis of the application effect of hospital-community-family ternary linkage nursing model in elderly patients with type 2 diabetes. General Nurs. 2021;19(21):2909–2911.
  • Hestevik CH, Molin M, Debesay J, Bergland A, Bye A. Older persons’ experiences of adapting to daily life at home after hospital discharge: a qualitative metasummary. BMC Health Serv Res. 2019;19(1):1–3. doi:10.1186/s12913-019-4035-z
  • Chan AH, Horne R, Hankins M, Chisari C. The medication adherence report scale: a measurement tool for eliciting patients’ reports of nonadherence. Br J Clin Pharmacol. 2020;86(7):1281–1288. doi:10.1111/bcp.14193